FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087330310> ?p ?o ?g. }

• W2087330310 endingPage "101" @default.
• W2087330310 startingPage "87" @default.
• W2087330310 abstract "1 We have evaluated the effects of intravenous or intraplantar racemic-, S(+)- and R(−)-flurbiprofen on both the carrageenan-evoked peripheral oedema and spinal c-Fos immunoreactivity, an indirect index of neurons involved in spinal nociceptive processes. 2 Three hours after intraplantar injection of carrageenan (6 mg in 150 μl of saline) in awake rats, a peripheral oedema and numerous c-Fos protein-like immunoreactive (c-Fos-LI) neurons in L4–L5 segments were observed. c-Fos-LI neurons were essentially located in the superficial (I–II) and deep (V–VI) laminae of the dorsal horn. 3 Intravenous racemic-flurbiprofen (0.3, 3 and 9 mg kg−1) dose-relatedly reduced the carrageenan-evoked oedema and spinal c-Fos expression (r=0.64, r=0.88 and r=0.84 for paw diameter, ankle diameter and number of c-Fos-LI neurons; P<0.05, P<0.001 and P<0.001 respectively). 4 Similar effects to those of intravenous racemic-flurbiprofen were obtained with intravenous S(+)-flurbiprofen (0.3, 3 and 9 mg kg−1) which dose-relatedly reduced the number of c-Fos-LI neurons (r=0.69, P<0.01) and diameters of paw and ankle (r=0.56 and r=0.52 respectively, P<0.05 for both). 5 For the dose of 0.3 mg kg−1 i.v., R(−)-flurbiprofen did not modify the number of c-Fos-LI neurons and produced a weak reduction of oedema at only the ankle level (23±12% reduction, P<0.05). However, a ten times higher dose of R(−)-flurbiprofen (3 mg kg−1 i.v.) was necessary to obtain effects comparable to those of S(+)- or racemic-flurbiprofen (0.3 mg kg−1 i.v.). 6 Intraplantar racemic-flurbiprofen (1, 10 and 30 μg) dose-relatedly reduced the carrageenan-enhanced ankle diameter (r=0.81, P<0.001) and the number of c-Fos-LI neurons in L4–L5 segments (r=0.83, P<0.001), with a 60±3% reduction of the number of c-Fos-LI neurons (P<0.001), and 30±3 and 67±7% reduction of paw and ankle diameter respectively (P<0.001 for both) for the dose of 30 μg. 7 For intraplantar S(+)-flurbiprofen (1, 10 and 30 μg) the dose-related effects (r=0.77, r=0.60 and r=0.59 for c-Fos-LI neurons, paw and ankle diameters respectively, P<0.001, P<0.01 and P<0.01) were similar to those of racemic-flurbiprofen. In contrast, intraplantar R(−)-flurbiprofen (1, 10 and 30 μg) did not have detectable effects on all studied parameters. 8 The present study provides clear evidence for potent anti-inflammatory and antinociceptive effects of both intravenous or intraplantar racemic- and S(+)-flurbiprofen. These results further demonstrate marked anti-inflammatory and antinociceptive effects of intravenous, but not intraplantar, R(−)-flurbiprofen. These results suggest that the main site of action of racemic- and S(+)-flurbiprofen is in the periphery and indicate that the site of action of R(−)-flurbiprofen is mainly of central origin. British Journal of Pharmacology (1998) 125, 87–101; doi:10.1038/sj.bjp.0702053" @default.
• W2087330310 created "2016-06-24" @default.
• W2087330310 creator A5056963078 @default.
• W2087330310 creator A5078518818 @default.
• W2087330310 date "1998-09-01" @default.
• W2087330310 modified "2023-10-15" @default.
• W2087330310 title "Peripheral and/or central effects of racemic-, S(+)- and R(−)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord" @default.
• W2087330310 cites W119932520 @default.
• W2087330310 cites W1536681507 @default.
• W2087330310 cites W1761965274 @default.
• W2087330310 cites W1904153590 @default.
• W2087330310 cites W1965584870 @default.
• W2087330310 cites W1969486060 @default.
• W2087330310 cites W1970782185 @default.
• W2087330310 cites W1978394930 @default.
• W2087330310 cites W1980024643 @default.
• W2087330310 cites W1980678458 @default.
• W2087330310 cites W1981819970 @default.
• W2087330310 cites W1984862078 @default.
• W2087330310 cites W1986726112 @default.
• W2087330310 cites W1987052599 @default.
• W2087330310 cites W1992819691 @default.
• W2087330310 cites W1993267975 @default.
• W2087330310 cites W1996462445 @default.
• W2087330310 cites W1997471203 @default.
• W2087330310 cites W2003321326 @default.
• W2087330310 cites W2012810767 @default.
• W2087330310 cites W2014005116 @default.
• W2087330310 cites W2014007136 @default.
• W2087330310 cites W2014652851 @default.
• W2087330310 cites W2022536454 @default.
• W2087330310 cites W2023265834 @default.
• W2087330310 cites W2023909595 @default.
• W2087330310 cites W2032743566 @default.
• W2087330310 cites W2033765046 @default.
• W2087330310 cites W2035274118 @default.
• W2087330310 cites W2035598134 @default.
• W2087330310 cites W2037864865 @default.
• W2087330310 cites W2038141648 @default.
• W2087330310 cites W2041272952 @default.
• W2087330310 cites W2041438513 @default.
• W2087330310 cites W2047920258 @default.
• W2087330310 cites W2049144348 @default.
• W2087330310 cites W2049481868 @default.
• W2087330310 cites W2051337621 @default.
• W2087330310 cites W2051792722 @default.
• W2087330310 cites W2052840755 @default.
• W2087330310 cites W2056994468 @default.
• W2087330310 cites W2062334130 @default.
• W2087330310 cites W2066647842 @default.
• W2087330310 cites W2066871600 @default.
• W2087330310 cites W2075429563 @default.
• W2087330310 cites W2078360083 @default.
• W2087330310 cites W2081244369 @default.
• W2087330310 cites W2087454739 @default.
• W2087330310 cites W2088804413 @default.
• W2087330310 cites W2096428903 @default.
• W2087330310 cites W2100135297 @default.
• W2087330310 cites W2101033679 @default.
• W2087330310 cites W2118800714 @default.
• W2087330310 cites W2120285683 @default.
• W2087330310 cites W2131485050 @default.
• W2087330310 cites W2146571040 @default.
• W2087330310 cites W4239425129 @default.
• W2087330310 cites W4245127772 @default.
• W2087330310 cites W4247000286 @default.
• W2087330310 cites W76378212 @default.
• W2087330310 doi "https://doi.org/10.1038/sj.bjp.0702053" @default.
• W2087330310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1565603" @default.
• W2087330310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9776348" @default.
• W2087330310 hasPublicationYear "1998" @default.
• W2087330310 type Work @default.
• W2087330310 sameAs 2087330310 @default.
• W2087330310 citedByCount "23" @default.
• W2087330310 countsByYear W20873303102012 @default.
• W2087330310 countsByYear W20873303102021 @default.
• W2087330310 crossrefType "journal-article" @default.
• W2087330310 hasAuthorship W2087330310A5056963078 @default.
• W2087330310 hasAuthorship W2087330310A5078518818 @default.
• W2087330310 hasBestOaLocation W20873303101 @default.
• W2087330310 hasConcept C104317684 @default.
• W2087330310 hasConcept C118552586 @default.
• W2087330310 hasConcept C126322002 @default.
• W2087330310 hasConcept C134018914 @default.
• W2087330310 hasConcept C150194340 @default.
• W2087330310 hasConcept C15490471 @default.
• W2087330310 hasConcept C170493617 @default.
• W2087330310 hasConcept C185592680 @default.
• W2087330310 hasConcept C2777397205 @default.
• W2087330310 hasConcept C2780323455 @default.
• W2087330310 hasConcept C2780775167 @default.
• W2087330310 hasConcept C2780886150 @default.
• W2087330310 hasConcept C2781000538 @default.
• W2087330310 hasConcept C2781227287 @default.
• W2087330310 hasConcept C42219234 @default.
• W2087330310 hasConcept C46762472 @default.
• W2087330310 hasConcept C55493867 @default.
• W2087330310 hasConcept C71924100 @default.

• next